Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin‐induced lactic acidosis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  British Journal of Pharmacology

• Publication date

  2012-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.2012.01853.xPMID 22242910PMCID PMC3417438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects

  2011cited by this paper
• Clinical Pharmacokinetics of Metformin

  2011influential reference
• Optimizing the technological and informational relationship of the health care process and of the communication between physician and patient. The impact of Preventive Medicine and social marketing applied in Health Care on youth awareness–Preliminary study

  2011cited by this paper
• Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics

  2011influential reference
• Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients.

  2010influential reference
• Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.

  2010cited by this paper
• Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin

  2010cited by this paper
• ABCG2 421C>A polymorphism and high exposure of sunitinib in a patient with renal cell carcinoma.

  2010cited by this paper
• Potent and Specific Inhibition of mMate1-Mediated Efflux of Type I Organic Cations in the Liver and Kidney by Pyrimethamine

  2010influential reference
• Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity

  2009cited by this paper
• Genetic Variation in the Multidrug and Toxin Extrusion 1 Transporter Protein Influences the Glucose-Lowering Effect of Metformin in Patients With Diabetes: A Preliminary Study

  2009cited by this paper
• Targeted Disruption of the Multidrug and Toxin Extrusion 1 (Mate1) Gene in Mice Reduces Renal Secretion of Metformin

  2009influential reference
• Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function

  2009cited by this paper
• SLCO1B1 variants and statin-induced myopathy--a genomewide study.

  2008cited by this paper
• Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters.

  2007influential reference
• Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2.

  2006cited by this paper
• SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

  2006cited by this paper
• A human transporter protein that mediates the final excretion step for toxic organic cations.

  2005cited by this paper
• Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1.

  2005cited by this paper
• Metformin and lactic acidosis: cause or coincidence? A review of case reports

  2004cited by this paper
• Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.

  2003cited by this paper
• Role of AMP-activated protein kinase in mechanism of metformin action.

  2001cited by this paper
• Lactic Acidosis With Therapeutic Metformin Blood Level in a Low-Risk Diabetic Patient

  1998cited by this paper
• Lactic acidosis in patients with diabetes treated with metformin.

  1998cited by this paper
• Lactic Acidosis With Therapeutic Metformin Blood Level in a Low-Risk Diabetic Patient

  1998cited by this paper
• Clinical Pharmacokinetics of Metformin

  1996cited by this paper
• Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR — an activator of AMP‐activated protein kinase

  1996cited by this paper
• Metformin-associated lactic acidosis.

  1996cited by this paper
• Metformin-induced lactic acidosis associated with acute renal failure.

  1996influential reference
• Metformin-lnduced Lactic Acidosis Associated with Acute Renal Failure

  1996influential reference
• Lactic acidosis due to metformin therapy in a low risk patient.

  1988cited by this paper

• Organic cation transporters 2: Structure, regulation, functions, and clinical implications.

  2025cites this paper
• Analysis of Genetic Polymorphisms of OCT1, MATE1, MATE2 and GLP1R in Rats with Experimentally Induced Obesity

  2024cites this paper
• Health disparities in the risk of severe acidosis: real-world evidence from the All of Us cohort

  2024cites this paper
• Regulatory mechanism of antioxidant enzymes on microbial metabolism and NADH in anaerobic fermentation of food waste for hydrogen production

  2024cites this paper
• Identification of clinical and pharmacogenetic factors influencing metformin response in Type 2 diabetes mellitus.

  2023cites this paper
• Thioacetamide-Induced Acute Liver Injury Increases Metformin Plasma Exposure by Downregulating Renal OCT2 and MATE1 Expression and Function

  2023cites this paper
• The role of MicroRNA networks in tissue-specific direct and indirect effects of metformin and its application.

  2022cites this paper
• Acute metabolic effects of metformin during critical illness

  2022cites this paper
• Renal trapping in accidental metformin intoxication

  2022cites this paper
• Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).

  2022cites this paper
• Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Metformin Hydrochloride.

  2021cites this paper
• The Current and Potential Therapeutic Use of Metformin—The Good Old Drug

  2021cites this paper
• The L125F MATE1 variant enriched in populations of Amerindian origin is associated with increased plasma levels of metformin and lactate.

  2021cites this paper
• Role of Membrane Transporters in Drug Disposition

  2021cites this paper
• Meta-Assessment of Metformin Absorption and Disposition Pharmacokinetics in Nine Species

  2021cites this paper
• Genomic editing of metformin efficacy-associated genetic variants in SLC47A1 does not alter SLC47A1 expression

  2021cites this paper
• Drug Transporters: Efflux

  2021cites this paper
• Rutaecarpine enhances the anti-diabetic activity and hepatic distribution of metformin via up-regulation of Oct1 in diabetic rats

  2021cites this paper
• Circadian Clock and Efflux Transporters

  2020cites this paper
• A Study of Associations Between Plasma Metformin Concentration, Lactic Acidosis, and Mortality in an Emergency Hospitalization Context.

  2020cites this paper
• Pharmacogenetics of Type 2 Diabetes—Progress and Prospects

  2020cites this paper
• Epigenetic markers associated with metformin response and intolerance in drug-naïve patients with type 2 diabetes

  2020cites this paper
• Organic Cation Transporters in Health and Disease

  2020cites this paper
• PPARα-Dependent Modulation by Metformin of the Expression of OCT-2 and MATE-1 in the Kidney of Mice

  2020cites this paper
• Increasing metformin concentrations and its excretion in both rat and porcine ex vivo normothermic kidney perfusion model

  2020cites this paper
• Metformin misuse in chronic kidney disease.

  2020cites this paper
• Circadian Pharmacokinetics

  2020cites this paper
• Application of genetically modified rodent models in drug discovery and development for translation of clinical ADME properties

  2020cites this paper
• Dysregulation of solute carrier transporters in malaria‐infected pregnant mice

  2019cites this paper
• The evidence of metabolic-improving effect of metformin in Ay/a mice with genetically-induced melanocortin obesity and the contribution of hypothalamic mechanisms to this effect

  2019cites this paper
• Mechanisms of Non-coenzyme Action of Thiamine: Protein Targets and Medical Significance

  2019cites this paper
• SLC Family Transporters.

  2019cites this paper
• Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicine

  2019cites this paper
• ABC Family Transporters.

  2019cites this paper
• Non-alcoholic Steatohepatitis (NASH) Drug Discovery - Building a Consensus on ADME Screening Tools and Clinical Pharmacology Strategies to Aid Candidate Development.

  2018cites this paper
• Relationship between DNA Methylation in the 5′ CpG Island of the SLC47A1 (Multidrug and Toxin Extrusion Protein MATE1) Gene and Interindividual Variability in MATE1 Expression in the Human Liver

  2018cites this paper
• Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro

  2018cites this paper
• Co‐administration of nuciferine reduces the concentration of metformin in liver via differential inhibition of hepatic drug transporter OCT1 and MATE1

  2018cites this paper
• The Effect of Dietary L-arginine on Malaria-Induced Dysregulation of Transporter Expression in a Murine Model of Placental Malaria

  2017cites this paper
• The effects of dietary and herbal phytochemicals on drug transporters☆

  2017cites this paper
• Is Metformin a Perfect Drug? Updates in Pharmacokinetics and Pharmacodynamics.

  2017cites this paper
• Renal Drug Transporters and Drug Interactions

  2017cites this paper
• Transporters Involved in Metformin Pharmacokinetics and Treatment Response.

  2017cites this paper
• Expression von Aufnahme-Transportern für Zytostatika in Mamma- und Prostatakarzinom-Zellen und ihre Interaktion mit Zytostatika

  2017cites this paper
• Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver

  2017cites this paper
• Mechanistic understanding of the effect of renal impairment on metformin oral absorption using computer simulations

  2017cites this paper
• Prolonged Hemodialysis: An Antidote for Metformin-Associated Lactic Acidosis.

  2016cites this paper
• The role of variants regulating metformin transport and action in women with polycystic ovary syndrome.

  2016cites this paper
• The Effect of Nizatidine, a MATE2K Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin in Healthy Volunteers

  2016cites this paper
• High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model

  2016cites this paper
• Different effect of testosterone and oestrogen on urinary excretion of metformin via regulating OCTs and MATEs expression in the kidney of mice

  2016cites this paper
• Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine

  2016cites this paper
• Metoprolol decreases the plasma exposure of metformin via the induction of liver, kidney and muscle uptake in rats

  2016cites this paper
• The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin

  2016cites this paper
• Organic Cation Transporters

  2016cites this paper
• Introduction to the Cellular Transport of Organic Cations

  2016cites this paper
• The Role of Transporters in Drug Delivery and Excretion

  2016cites this paper
• Translational Relevance of Animal Models for the Study of Organic Cation Transporter Function

  2016cites this paper
• Pharmacological and Toxicological Significance of the Organic Cation Transporters OCT and MATE: Drug Disposition, Interaction and Toxicity

  2016cites this paper
• Influences of MATE1 Gene Polymorphism on Metformin Induce Lactic Acidosis in Type 2 Diabetes Patients

  2016cites this paper
• Role of drug transporters: an overview based on knockout animal model studies

  2015cites this paper
• Multidrug and toxin extrusion 1 and human organic cation transporter 1 polymorphisms in patients with castration-resistant prostate cancer receiving metformin (SAKK 08/09)

  2015cites this paper
• Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury

  2015cites this paper
• The application of computer simulation to investigate drug absorption and bioavailability in disease states

  2015cites this paper
• Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis

  2015influential citation
• Metformin and other antidiabetic agents in renal failure patients.

  2015cites this paper
• Animal Models of Diabetic Macrovascular Complications: Key Players in the Development of New Therapeutic Approaches

  2015cites this paper
• Pharmacokinetic and Pharmacodynamic Interaction Between Gemigliptin and Metformin in Healthy Subjects

  2014cites this paper
• Pharmacogenomics of solute carrier transporter genes in the Xhosa population

  2014cites this paper
• Multidrug and Toxin Extrusion Proteins

  2014cites this paper
• [Progress in the study of multidrug and toxin extrusion proteins].

  2014cites this paper
• A consensus statement on the renal monitoring of Australian patients receiving tenofovir based antiviral therapy for HIV/HBV infection

  2014cites this paper
• Identification and functional characterization of novel MATE1 genetic variations in Koreans.

  2013cites this paper
• Pharmacogenetic variation and metformin response.

  2013cites this paper
• Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.

  2013cites this paper
• Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects.

  2013cites this paper
• Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin.

  2013cites this paper
• Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics.

  2013cites this paper
• Organic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney

  2013cites this paper
• Cation-selective Apical Transporters Mediate an Intestinal Cycling Mechanism of Metformin that Enhances its Paracellular Oral Absorption in Mice

  2013influential citation
• The synthesis and biodistribution of [(11)C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo.

  2013cites this paper
• Trimethoprim-metformin interaction and its genetic modulation by OCT2 and MATE1 transporters.

  2013cites this paper
• Bile formation and secretion.

  2013cites this paper
• Multidrug and toxin extrusion proteins as transporters of antimicrobial drugs

  2012cites this paper